Trial Profile
Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Clomipramine
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- Acronyms QCAT
- 11 Dec 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 04 Feb 2008 Status changed from in progress to completed.
- 13 Dec 2007 New trial record.